nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A4—bone cancer	0.821	1	CbGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00313	0.147	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00149	0.0701	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP4V2—bone cancer	0.00135	0.0631	CbGpPWpGaD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00133	0.0622	CbGpPWpGaD
Eplerenone—Hydrocortamate—CYP3A4—bone cancer	0.00108	0.205	CrCbGaD
Eplerenone—Cortisone acetate—CYP3A4—bone cancer	0.00106	0.202	CrCbGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000959	0.045	CbGpPWpGaD
Eplerenone—Drospirenone—PTGS2—bone cancer	0.000873	0.166	CrCbGaD
Eplerenone—NR3C2—Generic Transcription Pathway—ZNF77—bone cancer	0.000763	0.0358	CbGpPWpGaD
Eplerenone—Urinary tract disorder—Cisplatin—bone cancer	0.000712	0.00467	CcSEcCtD
Eplerenone—Connective tissue disorder—Cisplatin—bone cancer	0.000709	0.00464	CcSEcCtD
Eplerenone—Urethral disorder—Cisplatin—bone cancer	0.000707	0.00463	CcSEcCtD
Eplerenone—Gynaecomastia—Methotrexate—bone cancer	0.000705	0.00462	CcSEcCtD
Eplerenone—Pulmonary oedema—Methotrexate—bone cancer	0.000701	0.0046	CcSEcCtD
Eplerenone—Blood urea increased—Epirubicin—bone cancer	0.000696	0.00456	CcSEcCtD
Eplerenone—Blood uric acid increased—Doxorubicin—bone cancer	0.000695	0.00455	CcSEcCtD
Eplerenone—Musculoskeletal pain—Doxorubicin—bone cancer	0.000691	0.00453	CcSEcCtD
Eplerenone—Ventricular tachycardia—Doxorubicin—bone cancer	0.000682	0.00447	CcSEcCtD
Eplerenone—Tinnitus—Cisplatin—bone cancer	0.000672	0.00441	CcSEcCtD
Eplerenone—Hyperkalaemia—Doxorubicin—bone cancer	0.00067	0.00439	CcSEcCtD
Eplerenone—Flushing—Cisplatin—bone cancer	0.000669	0.00439	CcSEcCtD
Eplerenone—Cardiac disorder—Cisplatin—bone cancer	0.000669	0.00439	CcSEcCtD
Eplerenone—Influenza like illness—Doxorubicin—bone cancer	0.000663	0.00434	CcSEcCtD
Eplerenone—Diabetes mellitus—Methotrexate—bone cancer	0.000658	0.00431	CcSEcCtD
Eplerenone—Pulmonary oedema—Epirubicin—bone cancer	0.000656	0.0043	CcSEcCtD
Eplerenone—Mediastinal disorder—Cisplatin—bone cancer	0.00065	0.00426	CcSEcCtD
Eplerenone—Blood urea increased—Doxorubicin—bone cancer	0.000644	0.00422	CcSEcCtD
Eplerenone—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.00064	0.03	CbGpPWpGaD
Eplerenone—Malnutrition—Cisplatin—bone cancer	0.000628	0.00411	CcSEcCtD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000627	0.0294	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000619	0.029	CbGpPWpGaD
Eplerenone—Flatulence—Cisplatin—bone cancer	0.000618	0.00405	CcSEcCtD
Eplerenone—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000616	0.0289	CbGpPWpGaD
Eplerenone—Diabetes mellitus—Epirubicin—bone cancer	0.000615	0.00403	CcSEcCtD
Eplerenone—Pulmonary oedema—Doxorubicin—bone cancer	0.000607	0.00398	CcSEcCtD
Eplerenone—Muscle spasms—Cisplatin—bone cancer	0.000603	0.00396	CcSEcCtD
Eplerenone—Medroxyprogesterone Acetate—CYP3A4—bone cancer	0.000595	0.113	CrCbGaD
Eplerenone—Ill-defined disorder—Cisplatin—bone cancer	0.000582	0.00382	CcSEcCtD
Eplerenone—Anaemia—Cisplatin—bone cancer	0.00058	0.0038	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000571	0.0268	CbGpPWpGaD
Eplerenone—Diabetes mellitus—Doxorubicin—bone cancer	0.000569	0.00373	CcSEcCtD
Eplerenone—Malaise—Cisplatin—bone cancer	0.000566	0.00371	CcSEcCtD
Eplerenone—Renal impairment—Epirubicin—bone cancer	0.000562	0.00369	CcSEcCtD
Eplerenone—Methyltestosterone—CYP3A4—bone cancer	0.00056	0.107	CrCbGaD
Eplerenone—Hyponatraemia—Epirubicin—bone cancer	0.000537	0.00352	CcSEcCtD
Eplerenone—Myalgia—Cisplatin—bone cancer	0.000534	0.0035	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000531	0.00348	CcSEcCtD
Eplerenone—Discomfort—Cisplatin—bone cancer	0.000528	0.00346	CcSEcCtD
Eplerenone—Renal impairment—Doxorubicin—bone cancer	0.00052	0.00341	CcSEcCtD
Eplerenone—Infection—Cisplatin—bone cancer	0.000509	0.00334	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000508	0.0238	CbGpPWpGaD
Eplerenone—Nervous system disorder—Cisplatin—bone cancer	0.000502	0.00329	CcSEcCtD
Eplerenone—Blood creatinine increased—Epirubicin—bone cancer	0.000501	0.00329	CcSEcCtD
Eplerenone—Dehydration—Epirubicin—bone cancer	0.000498	0.00326	CcSEcCtD
Eplerenone—Skin disorder—Cisplatin—bone cancer	0.000498	0.00326	CcSEcCtD
Eplerenone—Hyponatraemia—Doxorubicin—bone cancer	0.000497	0.00326	CcSEcCtD
Eplerenone—Hyperhidrosis—Cisplatin—bone cancer	0.000495	0.00325	CcSEcCtD
Eplerenone—Eosinophilia—Methotrexate—bone cancer	0.000489	0.00321	CcSEcCtD
Eplerenone—Orthostatic hypotension—Epirubicin—bone cancer	0.000489	0.0032	CcSEcCtD
Eplerenone—Hypokalaemia—Epirubicin—bone cancer	0.000487	0.00319	CcSEcCtD
Eplerenone—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000482	0.0226	CbGpPWpGaD
Eplerenone—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000482	0.00316	CcSEcCtD
Eplerenone—Hypotension—Cisplatin—bone cancer	0.000479	0.00314	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000472	0.00309	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000467	0.00306	CcSEcCtD
Eplerenone—Blood creatinine increased—Doxorubicin—bone cancer	0.000464	0.00304	CcSEcCtD
Eplerenone—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000463	0.0217	CbGpPWpGaD
Eplerenone—Dehydration—Doxorubicin—bone cancer	0.000461	0.00302	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Methotrexate—bone cancer	0.000459	0.00301	CcSEcCtD
Eplerenone—Eosinophilia—Epirubicin—bone cancer	0.000458	0.003	CcSEcCtD
Eplerenone—Dyspnoea—Cisplatin—bone cancer	0.000457	0.00299	CcSEcCtD
Eplerenone—Orthostatic hypotension—Doxorubicin—bone cancer	0.000452	0.00296	CcSEcCtD
Eplerenone—Hypokalaemia—Doxorubicin—bone cancer	0.000451	0.00295	CcSEcCtD
Eplerenone—Angina pectoris—Epirubicin—bone cancer	0.000451	0.00295	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000446	0.00292	CcSEcCtD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000446	0.0209	CbGpPWpGaD
Eplerenone—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000445	0.0209	CbGpPWpGaD
Eplerenone—Bronchitis—Epirubicin—bone cancer	0.000445	0.00292	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—bone cancer	0.000443	0.00291	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000442	0.0029	CcSEcCtD
Eplerenone—Infestation—Methotrexate—bone cancer	0.000441	0.00289	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—bone cancer	0.000441	0.00289	CcSEcCtD
Eplerenone—Depression—Methotrexate—bone cancer	0.000439	0.00288	CcSEcCtD
Eplerenone—Pain—Cisplatin—bone cancer	0.000438	0.00287	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000437	0.00286	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—bone cancer	0.000433	0.00284	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Epirubicin—bone cancer	0.00043	0.00282	CcSEcCtD
Eplerenone—Eosinophilia—Doxorubicin—bone cancer	0.000424	0.00278	CcSEcCtD
Eplerenone—Feeling abnormal—Cisplatin—bone cancer	0.000422	0.00277	CcSEcCtD
Eplerenone—Hydrocortisone—CYP3A4—bone cancer	0.000422	0.0803	CrCbGaD
Eplerenone—Haematuria—Methotrexate—bone cancer	0.00042	0.00275	CcSEcCtD
Eplerenone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000419	0.0197	CbGpPWpGaD
Eplerenone—Hyperglycaemia—Epirubicin—bone cancer	0.000417	0.00274	CcSEcCtD
Eplerenone—Angina pectoris—Doxorubicin—bone cancer	0.000417	0.00273	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—bone cancer	0.000417	0.00273	CcSEcCtD
Eplerenone—Pneumonia—Epirubicin—bone cancer	0.000415	0.00272	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000413	0.0193	CbGpPWpGaD
Eplerenone—Infestation NOS—Epirubicin—bone cancer	0.000412	0.0027	CcSEcCtD
Eplerenone—Infestation—Epirubicin—bone cancer	0.000412	0.0027	CcSEcCtD
Eplerenone—Bronchitis—Doxorubicin—bone cancer	0.000412	0.0027	CcSEcCtD
Eplerenone—Renal failure—Epirubicin—bone cancer	0.000405	0.00266	CcSEcCtD
Eplerenone—Body temperature increased—Cisplatin—bone cancer	0.000405	0.00265	CcSEcCtD
Eplerenone—Neuropathy peripheral—Epirubicin—bone cancer	0.000404	0.00265	CcSEcCtD
Eplerenone—Urinary tract infection—Epirubicin—bone cancer	0.000401	0.00263	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000398	0.00261	CcSEcCtD
Eplerenone—Haematuria—Epirubicin—bone cancer	0.000393	0.00258	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—bone cancer	0.000393	0.00257	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—bone cancer	0.000391	0.00256	CcSEcCtD
Eplerenone—Hepatobiliary disease—Epirubicin—bone cancer	0.00039	0.00256	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—bone cancer	0.000388	0.00254	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—bone cancer	0.000386	0.00253	CcSEcCtD
Eplerenone—Pneumonia—Doxorubicin—bone cancer	0.000384	0.00252	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—bone cancer	0.000382	0.0025	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—bone cancer	0.000382	0.0025	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—bone cancer	0.000375	0.00246	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000374	0.00245	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—bone cancer	0.000371	0.00243	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—bone cancer	0.000369	0.00242	CcSEcCtD
Eplerenone—Hypoaesthesia—Epirubicin—bone cancer	0.000368	0.00241	CcSEcCtD
Eplerenone—Asthenia—Cisplatin—bone cancer	0.000368	0.00241	CcSEcCtD
Eplerenone—Pharyngitis—Epirubicin—bone cancer	0.000367	0.00241	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—bone cancer	0.000367	0.00241	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—ZNF77—bone cancer	0.000367	0.0172	CbGpPWpGaD
Eplerenone—Urinary tract disorder—Epirubicin—bone cancer	0.000366	0.0024	CcSEcCtD
Eplerenone—Oedema peripheral—Epirubicin—bone cancer	0.000365	0.00239	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—bone cancer	0.000364	0.00239	CcSEcCtD
Eplerenone—Connective tissue disorder—Epirubicin—bone cancer	0.000364	0.00239	CcSEcCtD
Eplerenone—Urethral disorder—Epirubicin—bone cancer	0.000363	0.00238	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—bone cancer	0.000361	0.00237	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—bone cancer	0.000359	0.00235	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—bone cancer	0.000357	0.00234	CcSEcCtD
Eplerenone—Diarrhoea—Cisplatin—bone cancer	0.00035	0.0023	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—bone cancer	0.000347	0.00227	CcSEcCtD
Eplerenone—Tinnitus—Epirubicin—bone cancer	0.000345	0.00226	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—bone cancer	0.000344	0.00226	CcSEcCtD
Eplerenone—Flushing—Epirubicin—bone cancer	0.000344	0.00225	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—bone cancer	0.000344	0.00225	CcSEcCtD
Eplerenone—Progesterone—CYP3A4—bone cancer	0.000343	0.0654	CrCbGaD
Eplerenone—Hypoaesthesia—Doxorubicin—bone cancer	0.000341	0.00223	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—bone cancer	0.00034	0.00223	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—bone cancer	0.000338	0.00222	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—bone cancer	0.000338	0.00221	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—bone cancer	0.000337	0.00221	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—bone cancer	0.000336	0.0022	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—bone cancer	0.000336	0.0022	CcSEcCtD
Eplerenone—Mediastinal disorder—Epirubicin—bone cancer	0.000334	0.00219	CcSEcCtD
Eplerenone—Back pain—Methotrexate—bone cancer	0.000333	0.00218	CcSEcCtD
Eplerenone—Vomiting—Cisplatin—bone cancer	0.000326	0.00213	CcSEcCtD
Eplerenone—Testosterone—CYP3A4—bone cancer	0.000325	0.0618	CrCbGaD
Eplerenone—Mental disorder—Epirubicin—bone cancer	0.000324	0.00213	CcSEcCtD
Eplerenone—Rash—Cisplatin—bone cancer	0.000323	0.00212	CcSEcCtD
Eplerenone—Dermatitis—Cisplatin—bone cancer	0.000323	0.00212	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—bone cancer	0.000322	0.00211	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—bone cancer	0.00032	0.00209	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—bone cancer	0.000319	0.00209	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—bone cancer	0.000318	0.00209	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—bone cancer	0.000318	0.00208	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—bone cancer	0.000318	0.00208	CcSEcCtD
Eplerenone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000318	0.0149	CbGpPWpGaD
Eplerenone—Flatulence—Epirubicin—bone cancer	0.000318	0.00208	CcSEcCtD
Eplerenone—Back pain—Epirubicin—bone cancer	0.000312	0.00204	CcSEcCtD
Eplerenone—Angiopathy—Doxorubicin—bone cancer	0.000311	0.00204	CcSEcCtD
Eplerenone—Malaise—Methotrexate—bone cancer	0.000311	0.00204	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—bone cancer	0.00031	0.00203	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—bone cancer	0.000309	0.00202	CcSEcCtD
Eplerenone—Nausea—Cisplatin—bone cancer	0.000304	0.00199	CcSEcCtD
Eplerenone—Cough—Methotrexate—bone cancer	0.000301	0.00197	CcSEcCtD
Eplerenone—Mental disorder—Doxorubicin—bone cancer	0.0003	0.00197	CcSEcCtD
Eplerenone—Ill-defined disorder—Epirubicin—bone cancer	0.000299	0.00196	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—bone cancer	0.000298	0.00195	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—bone cancer	0.000298	0.00195	CcSEcCtD
Eplerenone—Flatulence—Doxorubicin—bone cancer	0.000294	0.00193	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—bone cancer	0.000293	0.00192	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—bone cancer	0.000293	0.00192	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—bone cancer	0.000293	0.00192	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000291	0.00191	CcSEcCtD
Eplerenone—Malaise—Epirubicin—bone cancer	0.000291	0.00191	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—bone cancer	0.00029	0.0019	CcSEcCtD
Eplerenone—Syncope—Epirubicin—bone cancer	0.000289	0.00189	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—bone cancer	0.000288	0.00189	CcSEcCtD
Eplerenone—Muscle spasms—Doxorubicin—bone cancer	0.000287	0.00188	CcSEcCtD
Eplerenone—Loss of consciousness—Epirubicin—bone cancer	0.000283	0.00186	CcSEcCtD
Eplerenone—Cough—Epirubicin—bone cancer	0.000281	0.00184	CcSEcCtD
Eplerenone—Infection—Methotrexate—bone cancer	0.000279	0.00183	CcSEcCtD
Eplerenone—Ill-defined disorder—Doxorubicin—bone cancer	0.000277	0.00181	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—bone cancer	0.000276	0.00181	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—bone cancer	0.000276	0.00181	CcSEcCtD
Eplerenone—Chest pain—Epirubicin—bone cancer	0.000274	0.0018	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—bone cancer	0.000274	0.0018	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—bone cancer	0.000274	0.0018	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—bone cancer	0.000273	0.00179	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000273	0.00179	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—bone cancer	0.000272	0.00178	CcSEcCtD
Eplerenone—Discomfort—Epirubicin—bone cancer	0.000271	0.00178	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP3A4—bone cancer	0.00027	0.0127	CbGpPWpGaD
Eplerenone—Malaise—Doxorubicin—bone cancer	0.000269	0.00176	CcSEcCtD
Eplerenone—Syncope—Doxorubicin—bone cancer	0.000267	0.00175	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP3A4—bone cancer	0.000266	0.0125	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000266	0.0125	CbGpPWpGaD
Eplerenone—Hypotension—Methotrexate—bone cancer	0.000263	0.00172	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000262	0.0123	CbGpPWpGaD
Eplerenone—Loss of consciousness—Doxorubicin—bone cancer	0.000262	0.00172	CcSEcCtD
Eplerenone—Infection—Epirubicin—bone cancer	0.000261	0.00171	CcSEcCtD
Eplerenone—Cough—Doxorubicin—bone cancer	0.00026	0.00171	CcSEcCtD
Eplerenone—Shock—Epirubicin—bone cancer	0.000259	0.0017	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—NR1I2—bone cancer	0.000258	0.0121	CbGpPWpGaD
Eplerenone—Nervous system disorder—Epirubicin—bone cancer	0.000258	0.00169	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000256	0.00168	CcSEcCtD
Eplerenone—Skin disorder—Epirubicin—bone cancer	0.000256	0.00167	CcSEcCtD
Eplerenone—Hyperhidrosis—Epirubicin—bone cancer	0.000254	0.00167	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—bone cancer	0.000254	0.00167	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—bone cancer	0.000254	0.00166	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—bone cancer	0.000254	0.00166	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—bone cancer	0.000254	0.00166	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000252	0.00165	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—bone cancer	0.000251	0.00164	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—bone cancer	0.000251	0.00164	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—bone cancer	0.000247	0.00162	CcSEcCtD
Eplerenone—Hypotension—Epirubicin—bone cancer	0.000246	0.00161	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000243	0.00159	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—bone cancer	0.000242	0.00159	CcSEcCtD
Eplerenone—Infection—Doxorubicin—bone cancer	0.000242	0.00159	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000241	0.0113	CbGpPWpGaD
Eplerenone—Pain—Methotrexate—bone cancer	0.00024	0.00158	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00024	0.00157	CcSEcCtD
Eplerenone—Shock—Doxorubicin—bone cancer	0.000239	0.00157	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—bone cancer	0.000239	0.00156	CcSEcCtD
Eplerenone—Insomnia—Epirubicin—bone cancer	0.000238	0.00156	CcSEcCtD
Eplerenone—Skin disorder—Doxorubicin—bone cancer	0.000236	0.00155	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—bone cancer	0.000235	0.00154	CcSEcCtD
Eplerenone—Dyspnoea—Epirubicin—bone cancer	0.000235	0.00154	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—bone cancer	0.000232	0.00152	CcSEcCtD
Eplerenone—Dyspepsia—Epirubicin—bone cancer	0.000232	0.00152	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—GSTP1—bone cancer	0.000231	0.0108	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Methotrexate—bone cancer	0.00023	0.00151	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTP1—bone cancer	0.000228	0.0107	CbGpPWpGaD
Eplerenone—Hypotension—Doxorubicin—bone cancer	0.000227	0.00149	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000227	0.00149	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—bone cancer	0.000227	0.00149	CcSEcCtD
Eplerenone—Pain—Epirubicin—bone cancer	0.000225	0.00147	CcSEcCtD
Eplerenone—Constipation—Epirubicin—bone cancer	0.000225	0.00147	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—bone cancer	0.000222	0.00146	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—bone cancer	0.000222	0.00146	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000222	0.00145	CcSEcCtD
Eplerenone—Insomnia—Doxorubicin—bone cancer	0.00022	0.00144	CcSEcCtD
Eplerenone—Dyspnoea—Doxorubicin—bone cancer	0.000217	0.00142	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—bone cancer	0.000217	0.00142	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000215	0.0101	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Epirubicin—bone cancer	0.000215	0.00141	CcSEcCtD
Eplerenone—Dyspepsia—Doxorubicin—bone cancer	0.000214	0.0014	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00021	0.00138	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—bone cancer	0.00021	0.00138	CcSEcCtD
Eplerenone—Pain—Doxorubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Eplerenone—Asthenia—Methotrexate—bone cancer	0.000202	0.00132	CcSEcCtD
Eplerenone—Feeling abnormal—Doxorubicin—bone cancer	0.000201	0.00131	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000199	0.0013	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—bone cancer	0.000199	0.0013	CcSEcCtD
Eplerenone—Abdominal pain—Doxorubicin—bone cancer	0.000192	0.00126	CcSEcCtD
Eplerenone—Body temperature increased—Doxorubicin—bone cancer	0.000192	0.00126	CcSEcCtD
Eplerenone—Diarrhoea—Methotrexate—bone cancer	0.000192	0.00126	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000192	0.00901	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000192	0.00899	CbGpPWpGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00019	0.00889	CbGpPWpGaD
Eplerenone—Asthenia—Epirubicin—bone cancer	0.000189	0.00124	CcSEcCtD
Eplerenone—Pruritus—Epirubicin—bone cancer	0.000186	0.00122	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—bone cancer	0.000186	0.00122	CcSEcCtD
Eplerenone—Diarrhoea—Epirubicin—bone cancer	0.00018	0.00118	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—FUS—bone cancer	0.000179	0.00841	CbGpPWpGaD
Eplerenone—Vomiting—Methotrexate—bone cancer	0.000179	0.00117	CcSEcCtD
Eplerenone—Rash—Methotrexate—bone cancer	0.000177	0.00116	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—bone cancer	0.000177	0.00116	CcSEcCtD
Eplerenone—Headache—Methotrexate—bone cancer	0.000176	0.00115	CcSEcCtD
Eplerenone—Asthenia—Doxorubicin—bone cancer	0.000175	0.00114	CcSEcCtD
Eplerenone—Dizziness—Epirubicin—bone cancer	0.000174	0.00114	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—bone cancer	0.000172	0.00113	CcSEcCtD
Eplerenone—Vomiting—Epirubicin—bone cancer	0.000167	0.0011	CcSEcCtD
Eplerenone—Nausea—Methotrexate—bone cancer	0.000167	0.00109	CcSEcCtD
Eplerenone—Diarrhoea—Doxorubicin—bone cancer	0.000167	0.00109	CcSEcCtD
Eplerenone—Rash—Epirubicin—bone cancer	0.000166	0.00109	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—bone cancer	0.000166	0.00109	CcSEcCtD
Eplerenone—Headache—Epirubicin—bone cancer	0.000165	0.00108	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—NDUFA12—bone cancer	0.000162	0.00759	CbGpPWpGaD
Eplerenone—Dizziness—Doxorubicin—bone cancer	0.000161	0.00106	CcSEcCtD
Eplerenone—Nausea—Epirubicin—bone cancer	0.000156	0.00102	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000156	0.0073	CbGpPWpGaD
Eplerenone—Vomiting—Doxorubicin—bone cancer	0.000155	0.00101	CcSEcCtD
Eplerenone—Rash—Doxorubicin—bone cancer	0.000153	0.00101	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—bone cancer	0.000153	0.00101	CcSEcCtD
Eplerenone—Headache—Doxorubicin—bone cancer	0.000152	0.001	CcSEcCtD
Eplerenone—Nausea—Doxorubicin—bone cancer	0.000145	0.000948	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—NT5C3A—bone cancer	0.000134	0.00629	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NR1I2—bone cancer	0.000124	0.00583	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000114	0.00537	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000113	0.00529	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTP1—bone cancer	9.79e-05	0.00459	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	9.66e-05	0.00453	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—EIF2S1—bone cancer	9.18e-05	0.0043	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP3A4—bone cancer	8.27e-05	0.00388	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	8.16e-05	0.00383	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—EZH2—bone cancer	7.97e-05	0.00374	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTP1—bone cancer	7.08e-05	0.00332	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	6.98e-05	0.00327	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NDUFA12—bone cancer	6.86e-05	0.00322	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ENO2—bone cancer	5.87e-05	0.00275	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NT5C3A—bone cancer	5.69e-05	0.00267	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—DHFR—bone cancer	5.45e-05	0.00255	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GNA11—bone cancer	5.09e-05	0.00239	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.08e-05	0.00238	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NDUFA12—bone cancer	4.96e-05	0.00233	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP3A4—bone cancer	4.62e-05	0.00216	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.59e-05	0.00215	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NT5C3A—bone cancer	4.11e-05	0.00193	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTP1—bone cancer	3.95e-05	0.00185	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.29e-05	0.00154	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.24e-05	0.00152	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ENO2—bone cancer	2.49e-05	0.00117	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—DHFR—bone cancer	2.31e-05	0.00108	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NDUFA12—bone cancer	2.31e-05	0.00108	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GNA11—bone cancer	2.16e-05	0.00101	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS2—bone cancer	2.05e-05	0.000959	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP3A4—bone cancer	1.96e-05	0.000918	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NT5C3A—bone cancer	1.91e-05	0.000896	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ENO2—bone cancer	1.8e-05	0.000844	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—bone cancer	1.67e-05	0.000785	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—DHFR—bone cancer	1.67e-05	0.000783	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GNA11—bone cancer	1.56e-05	0.000732	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP3A4—bone cancer	1.42e-05	0.000663	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—bone cancer	1.21e-05	0.000567	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS2—bone cancer	8.67e-06	0.000407	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ENO2—bone cancer	8.37e-06	0.000392	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—DHFR—bone cancer	7.76e-06	0.000364	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GNA11—bone cancer	7.26e-06	0.00034	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS2—bone cancer	6.27e-06	0.000294	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—bone cancer	5.63e-06	0.000264	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS2—bone cancer	2.91e-06	0.000137	CbGpPWpGaD
